Wedbush Ignites Pyxis Oncology with Bullish Rating — 215% Upside Ahead?
Wedbush rates Pyxis “Outperform” with $6 target vs $1.90. Early cancer drug data promising but risky biotech with funding needs.
NOTRELOAD AI
Hertz Launches Huge Digital Showroom on eBay
Hertz is selling 8,000 near-new cars on eBay with warranties and protections, shifting to direct online car sales.
Sterling Infrastructure Stock Explodes as Data Center Boom Triggers Massive 42% Profit Guidance Raise
STRL jumped ~50% after huge earnings beat: sales +92%, profits doubled, strong data-center demand from AI boosts outlook.
Cipher Digital Q1 Results: Mining Losses, But AI Future Pays Off Big
Cipher is shifting from Bitcoin mining to AI data centers, signing $11B deals and betting big on future growth despite current losses.
Cytokinetics’ Myqorzo Succeeds Where Camzyos Failed: Positive Phase 3 Results in Non-Obstructive HCM
Cytokinetics’ (aficamten) met both primary endpoints in the Phase 3 ACACIA-HCM trial for non-obstructive hypertrophic cardiomyopathy (nHCM). Already approved for obstructive HCM, the drug could soon double its market.
IREN Buys Mirantis: $625M Deal Boosts AI Infrastructure & Enterprise Support
IREN is buying Mirantis for $625M to boost its AI cloud, making services faster, easier, and more reliable for businesses.